Anaemia management and mortality risk in newly visiting patients with chronic kidney disease in Japan: The CKD‐ROUTE study

Publisher： John Wiley & Sons Inc

E-ISSN： 1440-1797|20|9|601-608

ISSN： 1320-5358

Source： NEPHROLOGY, Vol.20, Iss.9, 2015-09, pp. : 601-608

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Anaemia with Erythropoiesis-Stimulating Agents in Patients with Chronic Kidney Disease Does Not Lower Mortality and May Increase Cardiovascular Risk: A Meta-Analysis

By  

Nephron Clin Pract, Vol. 121, Iss. 3-4, 2012-11 ,pp. : c95-c101

Karger

Access to resources Recommend Favorite

Epoetin delta, erythropoietin produced in a human cell line, in the management of anaemia in predialysis chronic kidney disease patients

By Kwan Jonathan T. C.   Pratt Raymond D.    

Current Medical Research and Opinion, Vol. 23, Iss. 2, 2007-02 ,pp. : 307-311

Informa Healthcare

Access to resources Recommend Favorite

Chronic hepatitis C virus (HCV) increases the risk of chronic kidney disease (CKD) while effective HCV treatment decreases the incidence of CKD

By  

HEPATOLOGY, Vol. 67, Iss. 2, 2018-02 ,pp. : 492-504

John Wiley & Sons Inc

Access to resources Recommend Favorite

Epoetin delta is effective for the management of anaemia associated with chronic kidney disease

By Spinowitz Bruce S.   Pratt Raymond D.    

Current Medical Research and Opinion, Vol. 22, Iss. 12, 2006-12 ,pp. : 2507-2513

Informa Healthcare

Access to resources Recommend Favorite

Implications of Neocytolysis for Optimal Management of Anaemia in Chronic Kidney Disease

By  

Nephron Clin Pract, Vol. 106, Iss. 4, 2007-06 ,pp. : c149-c156

Karger

Access to resources Recommend Favorite